Is AFJKU Stock Undervalued?

A comprehensive valuation analysis of Aimei Health Technology Co., Ltd. (AFJKU) examining current multiples, intrinsic value, and comparing to analyst expectations.

Updated March 19, 2026•8 min read•View Full Analysis

Valuation Verdict

↑

Potentially Undervalued

140399919.8% upside potential

Based on our analysis, Aimei Health Technology Co., Ltd. appears to be potentially undervalued at the current price of $27.61. Our fair value estimate of $38764445.48 suggests upside potential of approximately 140399919.8%.

Current Valuation Metrics

Valuation ratios help us understand how the market is pricing AFJKU relative to its fundamentals. Let's examine the key multiples investors are paying today.

P/E Ratio

N/A

P/B Ratio

N/A

P/S Ratio

N/A

EV/EBITDA

N/A

Understanding the Metrics

P/E Ratio: Not currently profitable or data unavailable.
P/B Ratio: Book value data not available.
P/S Ratio: Revenue data not available.
EV/EBITDA: EBITDA data not available.

Fair Value Estimate

Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Aimei Health Technology Co., Ltd. stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.

Current Price

$27.61

Fair Value Estimate

$38764445.48

Implied Return+140399919.8%

Our DCF model suggests AFJKU may be undervalued by approximately 140399919.8%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.

Investment Conclusion

Bottom Line

Based on our comprehensive valuation analysis, Aimei Health Technology Co., Ltd. (AFJKU) appears to be undervalued at $27.61. With a fair value estimate of $38764445.48, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.